CLZNY (CLZNY) Stock Price & Analysis
CLZNY (CLZNY) rose 0.00% to USD 9.86 as of June 10, 2026 at 03:34 UTC, according to Nexqual real-time market data.
CLZNY last closed at USD 9.86; the session ranged USD 9.86–10 on volume of 900 shares. Market capitalization is $3.24B, with a 52-week range of USD 8.45–12.16 (PNK). Source: Nexqual, June 10, 2026 at 03:34 UTC.
Key Statistics (as of June 10, 2026 at 03:34 UTC)
| Price | USD 9.86 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 9.86 |
| Open | USD 10 |
| Day Range | USD 9.86 – 10 |
| 52-Week Range | USD 8.45 – 12.16 |
| Volume | 900 shares |
| Market Cap | $3.24B |
| Exchange | PNK |
Technical Analysis (CLZNY)
Nexqual's technical model rates CLZNY "SELL" based on 1 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 03:34 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.54 (neutral) |
| vs SMA50 | Below (USD 10.37) |
| MACD | -0.15 (negative) |
Analyst Ratings (CLZNY)
Wall Street analysts rate CLZNY "None", per Nexqual as of June 10, 2026 at 03:34 UTC.
| Consensus Rating | None |
|---|
Earnings (CLZNY)
Source: Nexqual, June 10, 2026 at 03:34 UTC.
Financials & Fundamentals (CLZNY)
| Total Revenue | $3.92B |
|---|---|
| Revenue Growth (YoY) | -7.10% |
| Gross Margin | +31.19% |
| Operating Margin | +18.82% |
| Profit Margin | -1.92% |
| ROE | -1.75% |
| Debt / Equity | 93.08 |
| Current Ratio | 1.64 |
| Total Cash | $617.00M |
| Total Debt | $2.03B |
| Free Cash Flow | $289.38M |
Source: Nexqual, June 10, 2026 at 03:34 UTC.
Financial Health Score (CLZNY)
Nexqual rates CLZNY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:34 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 31%, operating 19% |
| Balance Sheet | Mixed — $617M cash vs $2.03B debt |
| Cash Flow | Solid — FCF $289M, 7% margin |
| Efficiency | Critical — ROE -2%, ROA 3.9% |
Ownership (CLZNY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 328.88M |
| Float | 194.59M |
Source: Nexqual, June 10, 2026 at 03:34 UTC.
Leadership (CLZNY)
CLZNY is led by Conrad Keijzer (age 57), Chief Executive Officer, per Nexqual as of June 10, 2026 at 03:34 UTC.
| Chief Executive Officer | Conrad Keijzer (age 57) |
|---|---|
| Chief Financial Officer | Oliver Rittgen |
| Chief Strategy & Technology Officer | Richard Haldimann |
| President of BU Care Chemicals & Americas Region | Christian Vang |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FUPBY | FUCHS SE | USD 11.17 | ▲ 1.45% |
| COVTY | Covestro AG | USD 33.7 | ▼ 0.06% |
| COIHY | Croda International Plc | USD 19.99 | ▲ 4.01% |
| BNTGY | Brenntag SE | USD 12.56 | ▼ 3.24% |
| BDNNY | Boliden AB | USD 109.64 | ▼ 3.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:34 UTC. This page is informational and not investment advice.